A study looking into how MDMA can be used to treat post traumatic stress disorder showed symptoms decreased to levels that could no longer be diagnosed as PTSD
MDMA, commonly referred to as “ecstasy” or “molly,” is on its way to becoming the first psychedelic to receive approval from the Food and Drug Administration (FDA) after a study conducted by an industry-leading research group found that the drug was effective in treating moderate and severe post-traumatic stress disorder (PTSD) among a racially diverse…